Sfoglia per AUTORE
DELIA M
Collezione AOU Alessandria

  

Items : 6

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.
2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. in EClinicalMedicine / EClinicalMedicine. 2024 Mar 18;71:102553. doi: 10.1016/j.eclinm.2024.102553. eCollection 2024 May.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cornely OA; Koehler P; Rahimli L; Hanáková M; Rá?il Z; Bonanni M; Nygaard M; García-Bordallo D; Çolak GM; Mayer J; Sacchi MV; Krekeler C; Infante MS; Jindra P; Zompi S; Mitrovi? M; Miškovi? B; Mladenovi? M; Coppola N; Otaševi? V; Prattes J; Gavriilaki E; Tragiannidis A; Groh A; Serrano L; Drgo?a ?; Serris A; Gonzaga Y; et alii...

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry. in Haematologica / Haematologica. 2024 Aug 1;109(8):2693-2700. doi: 10.3324/haematol.2023.284678.
2024
AOU Alessandria
AOU San Luigi di Orbassano

Prin R; Wolf D; Arellano E; Ammatuna E; Nordlander A; Cabirta A; Cordoba R; Garcia-Bordallo D; Tragiannidis A; Rodrigues RN; Vehreschild M; Ra?il Z; Hanakova M; Lievin R; Mitrovic M; Garcia-Sanz R; Cvetanoski M; Varricchio G; Bahr NC; Emarah Z; De Ramon C; Meers S; Di Blasi R; Mendez GA; Pantic N; Stojanoski Z; Erben N; Groh A; Cattaneo C; et alii...

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2023 Oct;62(4):106952. doi: 10.1016/j.ijantimicag.2023.106952. Epub 2023 Au
2023
AOU Alessandria
AOU San Luigi di Orbassano

Mladenovi? M; Bavastro M; Limongelli A; Rahimli L; Miškovi? B; Marchetti M; Nordlander A; Blennow O; Cordoba R; Wolf D; Çolak GM; Arellano E; Hersby DS; Gräfe S; Kohn M; Calbacho M; Besson C; Dargenio M; Del Principe MI; Glenthøj A; Fouquet G; Hernández-Rivas JÁ; Labrador J; Merelli M; Pantic N; Mitrovic M; Schönlein M; Gavriilaki E; Tragiannidis A; et alii...

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. in EClinicalMedicine / EClinicalMedicine. 2023 Apr;58:101939. doi: 10.1016/j.eclinm.2023.101939. Epub 2023 Apr 6.
2023
AOU Alessandria
AOU San Luigi di Orbassano

Blennow O; Nordlander A; Cabirta A; Cattaneo C; Merelli M; Hernández-Rivas JÁ; Aujayeb A; Jiménez M; Nucci M; Papa MV; Plantefeve G; Del Principe MI; Duléry R; Anastasopoulou AN; De Jonge N; Tascini C; Fernández N; Batini? J; Ormazabal-Vélez I; Cuccaro A; Lahmer T; Valkovi? T; Biernat MM; Besson C; Finizio O; Marques de Almeida J; Marchetti M; Weinbergerová B; Delia M; et alii...

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Pagliuca A; Passamonti F; Bonanni M; Labrador J; Rahimli L; Verga L; Cattaneo C; Adži?-Vuki?evi? T; Machado M; Gräfe S; Sili U; Hanáková M; Nucci M; Mladenovi? M; Liévin R; Prezioso L; Rá?il Z; Guidetti A; Demirkan F; Sacchi MV; Fernández N; Zambrotta G; Fouquet G; Marchetti M; Batini? J; Aujayeb A; de Jonge N; de Ramón C; et alii...